II
LXRX icon

Inspire Investing’s Lexicon Pharmaceuticals LXRX Stock Holding History

Inspire Investing’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,059
Closed -$87K – 304
2018
Q4 		$87K Buy
13,059
+3,030
+30% +$24.5K 0.06% 222
2018
Q3 		$107K Buy
+10,029
New +$115K 0.07% 226
2018
Q1 		– Sell
-5,585
Closed -$55K – 484
2017
Q4 		$55K Buy
+5,585
New +$58K 0.05% 627

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Inspire Investing's LXRX Position: Q1 2019 in Review

Inspire Investing sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2019, closing a stake of 13,059 shares — an estimated $87K sold.

Inspire Investing first reported a position in LXRX in Q4 2017 and held it in 3 quarters. The position peaked at $107K in Q3 2018. 121 funds tracked by Wall St. Rank hold LXRX as of Q1 2019.

  • Inspire Investing reported no remaining Lexicon Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Inspire Investing sold 13,059 Lexicon Pharmaceuticals shares in Q1 2019, an estimated $87K.
  • Inspire Investing first reported a position in Lexicon Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Inspire Investing's Lexicon Pharmaceuticals position peaked at $107K in Q3 2018.
  • 121 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2019.

Based on Inspire Investing's 13F filing for Q1 2019, filed 16 May 2019.